LUND,
Sweden, May 16, 2022 /PRNewswire/
-- Immunovia (Nasdaq Stockholm: IMMNOV) has appointed
Natalie Carfora as Head of Market
Access of its US subsidiary, Immunovia, Inc. Natalie brings deep
expertise to the reimbursement process from prior market access
roles at Scipher Medicine and Myriad Genetics. Natalie will take up
her position on May 23, 2022.
"The hire of Natalie as Head of Market Access in the US is
another key hire in-line with our strategic priority to strengthen
our US team for a commercial scale up of IMMray™ PanCan-d in the
US. Natalie will be instrumental in the pursuit of reimbursement
coverage for IMMray™ PanCan-d in the US, the largest and most
attractive diagnostic market globally in which Immunovia is
commercializing its novel test since August last year", says
Philipp Mathieu, Acting CEO and
President, Immunovia AB.
"Establishing reimbursement for IMMray™ PanCan-d, the only
blood test available for the early detection of pancreatic cancer,
is important to achieving widespread use. Natalie Carfora has a track record of securing
reimbursement for novel tests in both a start-up environment at
Scipher Medicine and at Myriad Genetics, one of the leading
diagnostic companies in the US. Adding her talents to the team is
another important step in driving the adoption and growth of
IMMray™ PanCan-d," says Jeff
Borcherding, CEO of Immunovia, Inc, Immunovia AB's US
subsidiary.
"Without precision medicine tools, patients suffer from
late-stage diagnosis and poor prognosis. People at risk for
pancreatic cancer need much better ways to detect cancer earlier.
The IMMray™ PanCan-d test is a compelling clinical option for
patients, providers, and payers. I am excited to partner with
payers to offer IMMray™ PanCan-d access to their members, leading
to improved clinical outcomes, increased patient satisfaction and
cost of care savings," says Natalie
Carfora.
Natalie Carfora brings over ten
years of sales and market access experience across biotechnology,
medical device, and pharmaceutical industries to the team. Building
partnerships through a variety of models across multiple channels
including payers, pharmacy benefit managers, and specialty
pharmacies, she is focused on optimizing patient care management.
Natalie is a graduate of Boston
University School of Management with a B.S. in Business
Administration.
For more information, please contact:
Philipp Mathieu
Acting CEO and President
Email: philipp.mathieu@immunovia.com
Tobias Bülow
Senior Director Investor Relations and Corporate Communications
Email: tobias.bulow@immunovia.com
Tel: +46 736 36 35 74
The information was submitted for publication on May 16, 2022, at 08:30 am
CET.
About Immunovia
Immunovia AB is a diagnostic company with the vision to
revolutionize blood-based diagnostics and increase survival rates
for patients with cancer.
Our first product, IMMray™ PanCan-d is the only blood test
currently available specifically for the early detection of
pancreatic cancer. The test has unmatched clinical performance.
Commercialization of IMMray™ PanCan-d started in August 2021 in the USA and IMMray™ PanCan-d is offered as a
laboratory developed test (LDT) exclusively through Immunovia, Inc.
For more information see: www.immunoviainc.com.
Immunovia collaborates and engages with healthcare providers,
leading experts and patient advocacy groups globally to make this
test available to all high-risk pancreatic cancer groups.
The USA, the first market in
which IMMray™ PanCan-d is commercially available, is the world's
largest market for the detection of pancreatic cancer with an
estimated value of more than USD 4
billion annually.
Immunovia's shares (IMMNOV) are listed on Nasdaq Stockholm. For
more information, please visit www.immunovia.com.
CONTACT:
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/immunovia-ab/r/immunovia-strengthens-its-us-team-through-the-appointment-of-natalie-carfora-as-head-of-market-acces,c3567469
The following files are available for download:
https://mb.cision.com/Main/13121/3567469/1580021.pdf
|
Press release
(PDF)
|
View original
content:https://www.prnewswire.com/news-releases/immunovia-strengthens-its-us-team-through-the-appointment-of-natalie-carfora-as-head-of-market-access-us-301547660.html
SOURCE Immunovia AB